Glassman Wealth Services’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,740
| Closed | -$24.8K | – | 1625 |
|
|
2023
Q4 | $24.8K | Sell |
1,740
-465
| -21% | -$6.64K | ﹤0.01% | 640 |
|
|
2023
Q3 | $34.1K | Buy |
2,205
+383
| +21% | +$5.93K | 0.01% | 522 |
|
|
2023
Q2 | $28.6K | Buy |
1,822
+27
| +2% | +$424 | ﹤0.01% | 541 |
|
|
2023
Q1 | $29.6K | Buy |
1,795
+178
| +11% | +$2.93K | 0.01% | 534 |
|
|
2022
Q4 | $25.2K | Sell |
1,617
-1
| -0.1% | -$16 | ﹤0.01% | 604 |
|
|
2022
Q3 | $21K | Sell |
1,618
-89
| -5% | -$1.16K | ﹤0.01% | 606 |
|
|
2022
Q2 | $24K | Buy |
1,707
+172
| +11% | +$2.42K | ﹤0.01% | 581 |
|
|
2022
Q1 | $22K | Buy |
1,535
+325
| +27% | +$4.66K | ﹤0.01% | 623 |
|
|
2021
Q4 | $16K | Buy |
1,210
+705
| +140% | +$9.32K | ﹤0.01% | 676 |
|
|
2021
Q3 | $8K | Buy |
505
+71
| +16% | +$1.13K | ﹤0.01% | 834 |
|
|
2021
Q2 | $7K | Buy |
434
+176
| +68% | +$2.84K | ﹤0.01% | 846 |
|
|
2021
Q1 | $5K | Sell |
258
-139
| -35% | -$2.69K | ﹤0.01% | 879 |
|
|
2020
Q4 | $7K | Buy |
397
+221
| +126% | +$3.9K | ﹤0.01% | 812 |
|
|
2020
Q3 | $3K | Buy |
176
+116
| +193% | +$1.98K | ﹤0.01% | 928 |
|
|
2020
Q2 | $1K | Sell |
60
-15
| -20% | -$250 | ﹤0.01% | 1111 |
|
|
2020
Q1 | $1K | Buy |
75
+36
| +92% | +$480 | ﹤0.01% | 989 |
|
|
2019
Q4 | $1K | Buy |
+39
| New | +$1K | ﹤0.01% | 1039 |
|